Penn Medicine Provider
Ophthalmology
Bennie Hau Jeng, MD
Accepting new patients
Sees patients age 18 and up
Scheie Eye Institute Penn Presbyterian

About me

  • Chair, Department of Ophthalmology
  • Director, Scheie Eye Institute at Penn Medicine
  • William F. Norris and George E. de Schweinitz Professor

Education and training

  • Medical School: University of Pennsylvania School of Medicine
  • Residency: Cleveland Clinic Foundation
  • Fellowship: University of California San Francisco

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Jeng is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Cohen EJ, Hochman JS, Troxel AB, Colby KA, Jeng BH; ZEDS Trial Research Group. Zoster Eye Disease Study: Rationale and Design , Cornea, 41: 2022,562-571


Roy A, Jeng BH, Chaurasia S, Das S. Overview of Short-Term and Intermediate-Term Corneal Storage Solution: Comparison of Clinical Outcomes and Need For Future Research , Eye Contact Lens, 48: 2022,141-148


Anesi SD, Tauber J, Nguyen QD, Chang P, Berdy GJ, Lin CC, Chu DS, Levine HT, Fernandez AD, Roy N, Asbell PA, Kantor AM, Chang AT, Singh B, Youngblood BA, Jeng BH, Jhanji V, Rasmussen HS, Foster CS. Lirentelimab for severe and chronic forms of allergic conjunctivitis , J Allergy Clin Immunol: 2022


Caputo R, Shapiro AD, Sartori MT, Leonardi A, Jeng BH, Nakar C, Di Pasquale I, Price FW Jr, Thukral N, Suffredini AL, Pino L, Crea R, Mathew P, Calcinai M. Treatment of Ligneous Conjunctivitis with Plasminogen Eyedrops , Ophthalmology: 2022


He X, Huang AS, Jeng BH. Optimizing the ocular surface prior to cataract surgery , Curr Opin Ophthalmol, 33: 2022,9-14


Jeng BH, Hamrah P, Kirshner ZZ, Mendez BC, Wessel HC, Brown LR, Steed DL. Exploratory Phase II Multicenter, Open-Label, Clinical Trial of ST266, a Novel Secretome for Treatment of Persistent Corneal Epithelial Defects , Transl Vis Sci Technol, 11: 2022,8


Zarei-Ghanavati S, Eslampoor A, Bausell RB, Jeng BH Results and complications of Boston Type I Kpro , Keratoprosthesis: 2022


Lockington D, Lee B, Jeng BH, Larkin DFP, Hjortdal J. Survey of Corneal Surgeons' Attitudes Regarding Keratoplasty Rejection Risk Associated With Vaccinations , Cornea, 40: 2021,1541-1547


Jeng BH. Prevention of Fungal Infection After Keratoplasty: The Utility of Adding an Antifungal to the Storage Medium (Pro Side) , Cornea, 40: 2021,1089-1090


Cohen EJ, Jeng BH. Herpes Zoster: A Brief Definitive Review , Cornea, 40: 2021,943-949